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Pilomyxoid astrocytomas (PMA) are new class of Pilocytic Astrocytoma (PA.), which typically have 
their origin in hypothalamus and Chiasmatic region. There are very few case reports of PMAs 
arising from cerebellum. Their imaging features are similar to PA but they behave more 
aggressively than PA. To increase awareness of PMA within the neurosurgical community, the 
authors reviewed a case of 11-year-old male child who presented with truncal and cerebellar 
ataxia and vomiting and right cerebellar tumor diagnosed as PA radiologically but PMA on 
histopathology examination. These findings indicate that PMA may be a unique entity that is 
distinct from PA, or it may be an unusual variant. 




Pilocytic astrocytomas are generally benign, typically showing 20-year survival rates of 70 to 80%, even 
when only a subtotal resection is achieved.1 These highly treatable and potentially curable pediatric 
tumors are considered Grade I neoplasms according to the World Health Organization tumor 
classification system.2, 3Prior to its recognition, PMA was grouped with PA, because the two display 
similar histological features. 
In 1999, Tihan and colleagues provided the sentinel description of PMAs.1 Because of their similar 
histological and radiological features, 2 PMAs were classified as PAs prior to acceptance of this 
publication. . Earlier reports pointed out unusual features of some pediatric astrocytomas, particularly 
those within the hypothalamic/chiasmatic region, but did not specifically use a term to distinguish them.4, 
5,9 
In contrast to PAs, PMAs demonstrate a more aggressive clinical course8-9 and appear to be associated 
with a higher incidence of leptomeningeal spread.9 Pilomyxoid astrocytomas are considered to be WHO 
Grade II neoplasms, and most often arise from the hypothalamic/chiasmatic region. However, PMAs 
sometimes originate from the posterior fossa.4whereas hypothalamic PMAs have been well described in 
the literature, there is a relative paucity of information about PMAs that arise from the cerebellum. 
Although limited clinical experience makes it difficult to generate conclusive prognostic data regarding 
this recently described pediatric tumor, PMA has been shown to behave more aggressively than PA .11 
Here we report a case of cerebellar PMA in a 11 year old male child and discuss literature review 
Case report 
This was an 11 year old male patient who was relatively in a good state of health prior to his presentation 
to neurosurgical referral clinics at which time he presented with global headache,projectile vomiting of 
ingested matter of one moth duration, these symptoms were associated with difficulty of maintaining 
balance, and blurring of vision.Physical examination revealed papilledema with positive Romberg’s 
test.Abnormal rapid alternating movements, and tandemwalk were indicative of cerebellar ataxia and 
truncal ataxia. Brain CT scan with contrast was done,  
Figure 1: First CT scan done on January 12, 2015 showed a cystic mass at cerebellar vermis measuring 5 
by 4 cm which had compressed the 4th ventricle with obstructive hydrocephalus 
128 
   ISSN 2073-9990   East Cent. Afr. J. surg  




With diagnostic impression of cerebellar Pilocytic astrocytoma, he was operated on 07/05/2015 midline 
sub-occipital craniectomy and gross total resection of the tumor was done, and patient was discharged 
with improvement after 10days of hospital stay. Initial biopsy result was Pilocytic Astrocytoma. After 
discharge patient resumed his daily normal activity and re started his education. On follow-up for 8 
months he was perfectly healthy at which time he started to have similar previous symptom such as 
global headache with difficulty of maintaining balance with frequent vomiting of ingested matter. Physical 
examination revealed papilledema with positive cerebellar sign.  
Figure 2: MRI with contrast of the brain, A-Axial View, B-Coronal View, C Sagittal view: all showing 
predominantly cystic posterior fossa mass with markedmass effect, protrusion of the mass through the 
surgical defect posteriorly tonsilar herniationand severe hydrocephalus 
 
 
With diagnostic impression of recurrent posterior fossa mass with mass effect and severe Hydrocephalus re-do 
surgery was decided and operative findings are described as follows.  
Operation: 
Patient under went reoperation on October 30,2015. The patient was placed on the operating table in 
prone position and in a pin head holder. Midline sub-occipital craniotomy and frizer bur hole done and 
temporary external ventricular drain was placed in the right lateral ventricle via posterior horn to lower 
the intracranial pressure by draining CSF.The dura mater did not show any abnormality. Despite the 
tumor had no capsule, it demarcated clearly with the normal tissues, so that it was not difficult to remove 
the tumor from the cerebellum. Gross total resection of the tumor was done. Tumor was grayish,firm non-
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The patient started to shoot low-grade fever at 3rdpostoperative day CSF analysis was taken and EVD was 
removed at 4th day. Cell count was high but culture was negative .He was treated with IV antibiotic with 
presumptive diagnosis of post operative meningitis and discharged improved after 18 days of hospital 
stay. Figure 3: shows Postoperative control Brain CT scan image done on 2 Nov 2015. Showing Gross total 
resection withsmall hematoma and questionable residual. 
 
Figure 3. brain CT scan, Axial View, showing postoperative state with small hematoma and with 
surgical bone defect 
Pathology report 
     
                      
Figure 4. H and E (hematoxylin and eosin stain) 200X. Parallel bundles of bipolar spindle cells with 
fibrillar cytoplasmic process set in myxoid stroma and aniocentric nature of he tumor cell close to the 
meninges is also demonstrable. 
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Histopathological examination of the specimen from reoperation wasdone on 8 November 2015: formalin 
fixed paraffin embedded, hematoxylin and eosine stained section demonstrate parallel band of bipolar 
spindle tumor cell with fibrillary cytoplasmic process set in myxoid stroma in places the tumor cell are 
arranged near the blood vessels. The angiocentric nature of the tumor cell the myxoid stromal and the 
proximity of the tumor to the meninges point to the diagnosis of pilomyxoid astrocytoma. 
Patient stayed 3 weeks in the hospital and treated for meningitis, finally discharged with marked 
improvement. Patient was sent to Radiotherapy center for Radiation therapy, but the oncologist decided 
not to give him radiation treatment. Currently, 4 months postoperatively he become asymptomatic and in 
a good state of health attending school. 
Discussion 
PMA have been reported in the English literature and the overwhelming majority of the patients were 
children aged from 2 months to 4 years.10Under the current WHO grading scheme, PAs are designated 
Grade I and PMAs are designated Grade II neoplasms8. Because of similar radiological and histological 
features, PMAs were considered PAs prior to their sentinel description in 1999.6 In contrast to the 
fibrillary background and biphasic cellular pattern observed with PAs, PMAs display a predominantly 
myxoid background with a perivascular arrangement of tumor cells, reminiscent of ependymomatous 
pseudorosettes. The myxoid background and angiocentric tumor cell arrangement are typically 
discernible on a low-magnification examination of H & E–stained material. Examination at high power 
then reveals a monomorphous population of small bipolar cells and an absence of Rosenthal fibers and 
Eosinophilic granular bodies.11 PMAs were typically seen in the chiasmatic-hypothalamic region, but they 
were also found in other locations, including the spinal cord, the temporal lobe, occipital lobe and sellar- 
suprasellar region.12, 13Histopathological differentiation within the pilomyxoid spectrum is based on 
morphological analysis of H & E–stained material; the utility of other methods of differentiation—
including immunohistochemical staining and molecular analysis—remains speculative at this time. 14,15 
In this case report, the diagnosis of PMA was made predominantly on the basis of histological features 
after first surgery. Histopathological distinction between PA and PMA is useful because PMAs have been 
associated with increased rates of local recurrence and leptomeningeal dissemination, as well as 
decreased overall survival relative to PAs.9Although it is not uncommon for conventional PAs to spread 
locally to involve the leptomeninges, the incidence of leptomeningeal dissemination in cerebellar PAs is 
extremely rare, 17 and many neurosurgeons do not routinely obtain MR imaging of the neuraxis to rule out 
leptomeningeal dissemination before or after resection.8 Thus, pathological designation in these patients 
may influence the frequency and scope of surveillance imaging. Histological features influence the risk-
benefit analysis of post resection adjuvant therapy as well. Complete surgical excision of a PA is believed 
to obviate the need for adjuvant therapy18; however, adjuvant chemotherapy has been recommended as 
initial therapy in the treatment of PMAs.16Whereas the literature is replete with clinical series of pediatric 
patients with hypothalamic/chiasmatic PMAs, descriptions of cerebellar PMAs are rare. In 1 compilation 
describing the radiological features of 21 patients with PMAs from 7 different institutions, 2 patients 
(10%) had tumors that arose from the cerebellum.2 In another compilation of 84 patients with 
pathological findings of pediatric astrocytomas with pilomyxoid features, 2 patients harbored cerebellar 
tumors.15In our case, the tumor was located in the midline region of the cerebellum, that blocked 
circulation pathway of cerebrospinal fluid and the initial symptoms were induced by increased 
intracranial pressure . 
On MRI, PMAs also have similar signal patterns to PA, and they both show isointensity on T1WI 
sequences, hyperintensity on T2WIssequences and on FLAIR images. However, some features could be 
used to distinguish PMA from PA on MRI. PAs are usually cystic with solid mural nodules and are 
surrounded by edema. When contrast medium was administered, PA often showed intense enhancement 
in the nodule or the cyst wall. On the contrary, PMAs are often demonstrates solid or cystic, tend to be 
well circumscribed, and has little to no calcification rarely with peripheral edema. In PMAs, 40% cases 
showed homogenous enhancement and 30%-60% cases displayed heterogeneous enhancement. (19,20) 
Furthermore, PMAs may exhibit peritumotral edema, mass effect and necrosis. 
our case, the tumor showed cyst with a mural nodule. Nodule displayed homogenous enhancement while 
cyst wall was non-enhancing. However, neuroimaging features cannot yet distinguish between PMA and 
PA, 19 and the diagnosis of PMA is made predominantly on the basis of distinctive histological features19, 21 
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Similar to Tihan T and collegues our patients with PMA, regardless of total or partial resection, a majority 
of the postoperative recurrences took place within one year and the local recurrence rate was 76%. 3 The 
average survival time was 6 months when MRI demonstrated a recurred tumor. 6, 13 
Conclusion 
PMA generally exhibits more aggressive biological behavior. Currently, there is no standard of care in 
treating patients with PMA. Surgical intervention remains the first step, with complete resection being the 
goal. Given the uncertainties about the prognosis of PMA, it is not possible to provide strict management 
guidelines at this stage. More definitive guidelines are certain to emerge as clinicians gain more 
experience with PMA in the future. 
Recommendation 
Histopathologist should look for features of PMAs whenever they consider the diagnosis of PAs, as this 
finding is important for the patient and surgeon for 
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